Exane Derivatives’s Evoqua Water Technologies Corp. Common Stock AQUA Stock Holding History

Exane Derivatives’s Portfolio AQUA Stock Details AQUA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$183K	Sell	5,638 -3,575	-39%	-$136K	0.11%	183
2022 Q1	$433K	Sell	9,213 -2,151	-19%	-$91.8K	0.12%	208
2021 Q4	$531K	Sell	11,364 -10,147	-47%	-$442K	0.13%	165
2021 Q3	$808K	Sell	21,511 -11,123	-34%	-$402K	0.19%	112
2021 Q2	$1.04M	Buy	32,634 +8,980	+38%	+$270K	0.24%	91
2021 Q1	$622K	Sell	23,654 -413	-2%	-$11K	0.18%	123
2020 Q4	$649K	Buy	24,067 +19,907	+479%	+$494K	0.19%	113
2020 Q3	$88.3K	Buy	+4,160	New	+$83K	0.03%	313

Other funds holding AQUA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Exane Derivatives's AQUA Position: Q2 2022 in Review

Exane Derivatives reduced its Evoqua Water Technologies Corp. Common Stock (AQUA) stake by 39% in Q2 2022, selling an estimated $136K and leaving 5,638 shares worth $183K. The position accounts for 0.11% of the portfolio, ranked #183.

Exane Derivatives first reported a position in AQUA in Q3 2020 and has held it in 8 quarters since. The position peaked at $1.04M in Q2 2021. 275 funds tracked by Wall St. Rank hold AQUA as of Q2 2022.

Exane Derivatives held 5,638 shares of Evoqua Water Technologies Corp. Common Stock worth $183K as of Q2 2022.
Exane Derivatives sold 3,575 Evoqua Water Technologies Corp. Common Stock shares in Q2 2022, an estimated $136K.
Evoqua Water Technologies Corp. Common Stock made up 0.11% of Exane Derivatives's portfolio in Q2 2022, its #183 holding.
Exane Derivatives first reported a position in Evoqua Water Technologies Corp. Common Stock in Q3 2020 and has held it in 8 quarters since.
Exane Derivatives's Evoqua Water Technologies Corp. Common Stock position peaked at $1.04M in Q2 2021.
275 funds tracked by Wall St. Rank held Evoqua Water Technologies Corp. Common Stock as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.